首站-论文投稿智能助手
典型文献
Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)
文献摘要:
Pancreatic cancer is a serious threat to human health, and the incidence is on the rise. Due to lack of obvious symptoms in early stage, it is often diagnosed in late stage. Its biological behavior is poor, and up to now, surgery and medical treatment have not achieved optimal effect, many efforts have been made to improve the diagnosis and treatment of pancreatic cancer. In 2022, the National Guidelines of Diagnosis and Treatment of pancreatic cancer 2022 in China (English version) (1) was updated and released by the National Health Commission of the People's Republic of China based on the 2018 edition. Some updated points will be discussed.
文献关键词:
作者姓名:
Kemin Jin;Baocai Xing
作者机构:
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Hepatobiliary and Pancreatic Surgery Unit I,Peking University Cancer Hospital&Institute,Beijing 100142,China
引用格式:
[1]Kemin Jin;Baocai Xing-.Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version))[J].中国癌症研究(英文版),2022(06):637-643
A类:
B类:
Comments,National,guidelines,diagnosis,treatment,pancreatic,cancer,China,English,version,Pancreatic,serious,threat,human,health,incidence,rise,Due,lack,obvious,symptoms,early,stage,often,diagnosed,late,Its,biological,behavior,poor,now,surgery,medical,have,not,achieved,optimal,effect,many,efforts,been,made,improve,In,Guidelines,Diagnosis,Treatment,was,updated,released,by,Health,Commission,People,Republic,edition,Some,points,will,discussed
AB值:
0.626751
相似文献
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
An international multicentric phase Ⅲ randomized controlled trial of time-acupoints-space acupuncture for the prevention of chemotherapy-induced fatigue in patients with early stage breast cancer:a study protocol
Saghachian Mahasti;Barry Caroline;Asselain Bernard;LI Yunfen;NIE Jianyun;LIU Dequan;CHEN Dedian;CHEN Chunxin;Laura Estevez;LI Wenhui;Jean-Pierre Armand;ZHU Miansheng;JU Liya-Institute Gustave Roussy,Paris,France;Research Center of Epidemiology and public health,Paris,France;Institute Curie of Paris,Paris,France;Yunnan Cancer Hospital,Third Affiliated Hospital of Kunming Medical University,Kunming,China;PreciMed Platform Europe,Paris,France,,MD Anderson Cancer Hospital,Madrid,Spain;ARIATAS Association pour la Recherche et l'Information de l'Acupuncture Time-Acupoints-Space,Paris,France
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。